We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.3B
AUM Growth
+$198M
Cap. Flow
+$75.1M
Cap. Flow %
5.78%
Top 10 Hldgs %
26.62%
Holding
265
New
28
Increased
44
Reduced
124
Closed
7

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$2.74M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.21M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.16M
5
AFL icon
Aflac
AFL
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Healthcare 14.97%
3 Financials 8.17%
4 Industrials 8.04%
5 Consumer Discretionary 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
26
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$14.8M 1.14%
35,207
-448
-1% -$173K
ROP icon
27
Roper Technologies
ROP
$39.8B
$14.7M 1.13%
34,071
+155
+0.5% +$63.7K
VWO icon
28
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$14.5M 1.11%
288,397
-2,846
-1% -$134K
NEE icon
29
NextEra Energy
NEE
$177B
$14.4M 1.11%
186,658
-4,226
-2% -$316K
MKC icon
30
McCormick & Company Non-Voting
MKC
$14.2B
$14.3M 1.1%
149,092
+560
+0.4% +$52.9K
VCSH icon
31
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$13.8M 1.06%
+166,210
New +$13.8M
CRM icon
32
Salesforce
CRM
$158B
$13.2M 1.01%
59,105
+10,704
+22% +$2.6M
IJR icon
33
iShares Core S&P Small-Cap ETF
IJR
$112B
$13.1M 1.01%
142,629
-3,505
-2% -$288K
PG icon
34
Procter & Gamble
PG
$339B
$13M 1%
93,670
-2,658
-3% -$371K
TEL icon
35
TE Connectivity
TEL
$62.6B
$13M 1%
107,051
+479
+0.4% +$52.8K
IDXX icon
36
Idexx Laboratories
IDXX
$46.2B
$11.8M 0.91%
23,669
-2,053
-8% -$919K
ABT icon
37
Abbott
ABT
$187B
$11.3M 0.87%
103,519
-359
-0.3% -$39K
ADBE icon
38
Adobe
ADBE
$105B
$11.3M 0.87%
22,505
+747
+3% +$361K
CVS icon
39
CVS Health
CVS
$122B
$11.1M 0.85%
161,872
+6,598
+4% +$429K
SEDG icon
40
SolarEdge
SEDG
$1.95B
$11M 0.85%
34,507
+10,453
+43% +$2.89M
QQQ icon
41
Invesco QQQ Trust
QQQ
$484B
$11M 0.84%
34,949
-1,365
-4% -$401K
PEP icon
42
PepsiCo
PEP
$190B
$10.8M 0.83%
72,839
-1,808
-2% -$257K
DHR icon
43
Danaher
DHR
$144B
$10.5M 0.81%
53,502
-1,594
-3% -$320K
FLOT icon
44
iShares Floating Rate Bond ETF
FLOT
$10.3B
$9.88M 0.76%
+194,870
New +$9.88M
DLTR icon
45
Dollar Tree
DLTR
$25.2B
$9.74M 0.75%
90,132
-1,918
-2% -$193K
ABBV icon
46
AbbVie
ABBV
$435B
$9.69M 0.75%
90,424
+6,123
+7% +$588K
GIS icon
47
General Mills
GIS
$19.7B
$9.19M 0.71%
156,213
-8,355
-5% -$505K
SPGI icon
48
S&P Global
SPGI
$120B
$8.97M 0.69%
27,290
-575
-2% -$194K
VZ icon
49
Verizon
VZ
$196B
$8.7M 0.67%
148,095
-5,024
-3% -$298K
XBI icon
50
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$8.7M 0.67%
61,778
-924
-1% -$118K

Similar funds

Boston Family Office's Q4 2020 Portfolio in Review

As of Q4 2020, Boston Family Office held 265 positions worth $1.3B, up 18% from $1.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office deployed $75.1M of net new capital in Q4 2020, opening 28 new positions and adding to 44 existing holdings. Its largest new stake was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marsh, an estimated $2.74M trimmed.

  • Boston Family Office's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.
  • Boston Family Office added most to SolarEdge in Q4 2020, an estimated $2.89M increase.
  • Boston Family Office's biggest Q4 2020 reduction was Marsh, cutting an estimated $2.74M.
  • Boston Family Office fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $1.4M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.3B portfolio in Q4 2020.
  • Boston Family Office opened 28 new positions and closed 7 in Q4 2020.
  • Boston Family Office's portfolio value rose 18% quarter-over-quarter to $1.3B.

Based on Boston Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.